HCG18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.96219995807212E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.98290003808432E-09 |
Normal-vs-Stage2 |
2.31129999994639E-06 |
Normal-vs-Stage3 |
1.15079945572916E-10 |
Normal-vs-Stage4 |
5.4460003173773E-10 |
Stage1-vs-Stage2 |
3.654800E-01 |
Stage1-vs-Stage3 |
5.302500E-03 |
Stage1-vs-Stage4 |
1.949820E-02 |
Stage2-vs-Stage3 |
3.829000E-01 |
Stage2-vs-Stage4 |
3.632800E-01 |
Stage3-vs-Stage4 |
9.351400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.07020003969893E-09 |
Normal-vs-AfricanAmerican |
4.837300E-04 |
Normal-vs-Asian |
2.721800E-02 |
Caucasian-vs-AfricanAmerican |
2.627800E-01 |
Caucasian-vs-Asian |
9.613400E-01 |
AfricanAmerican-vs-Asian |
6.967600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.02060035370266E-10 |
Normal-vs-Female |
6.29109999983335E-07 |
Male-vs-Female |
5.217200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.157400E-04 |
Normal-vs-Age(41-60Yrs) |
1.50290002665088E-09 |
Normal-vs-Age(61-80Yrs) |
6.9568995009206E-10 |
Normal-vs-Age(81-100Yrs) |
1.785410E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.802800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.200000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.870000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.411010E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.009800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.682800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.238200E-01 |
Normal-vs-Grade 2 |
4.060000002859E-08 |
Normal-vs-Grade 3 |
6.51609877166948E-11 |
Normal-vs-Grade 4 |
3.59310359243636E-11 |
Grade 1-vs-Grade 2 |
3.727900E-02 |
Grade 1-vs-Grade 3 |
3.014100E-04 |
Grade 1-vs-Grade 4 |
1.247530E-04 |
Grade 2-vs-Grade 3 |
1.101700E-03 |
Grade 2-vs-Grade 4 |
1.102790E-03 |
Grade 3-vs-Grade 4 |
2.601600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.15450000001982E-06 |
Normal-vs-ccB subtype |
1.04260045041826E-10 |
ccA subtype-vs-ccB subtype |
1.035250E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.28749999550593E-08 |
Normal-vs-N1 |
1.155630E-04 |
N0-vs-N1 |
1.563560E-01 |
|
|